Hunter Kellogg

Hunter Kellogg is an Associate Scientist II in the Discovery group at GentiBio. Prior to GentiBio, Hunter worked in Assay Development at Kephera Diagnostics, where he aided in developing novel point-of-care diagnostics for neglected and emerging infectious diseases. Hunter received his BS in Public Health from Kent State University and his MS in Infectious Disease and Global Health from Tufts University. At Tufts University, Hunter gained laboratory experience across many facets of microbiology, immunology, and molecular biology. His projects included the development of monoclonal antibodies against Stx-producing E. Coli, the characterization of Schistosome surface proteins, and drug efficacy trials in the murine model.